ISSVA 2026 | 澶嶆槦鍖昏嵂鍒涙柊鑽杩堝畞庐涓洪澶朅VM鎮h€呭甫鏉ラ澏鍚戞不鐤楁柊甯屾湜



杩戞棩锛屽浗闄呰剦绠℃€х柧鐥呯爺绌跺浼氾紙ISSVA锛夊ぇ浼氫簬缇庡浗璐瑰煄闅嗛噸鍙紑銆傚鏄熷尰鑽嚜涓荤爺鍙戠殑MEK1/2鎶戝埗鍓傝姦娌冪編鏇垮凹锛堜腑鍥藉鍐呭晢鍝佸悕锛氬杩堝畞庐锛夋不鐤楁垚浜洪澶栧姩闈欒剦鐣稿舰锛圓VM锛夌殑II鏈熶复搴婄爺绌舵暟鎹紝鍏ラ€塈SSVA澶т細娴锋姤灞曠ず銆傛湰鐮旂┒鐢变笂娴蜂氦閫氬ぇ瀛﹀尰瀛﹂櫌闄勫睘绗節浜烘皯鍖婚櫌鏋楁檽鏇︽暀鎺堢壍澶村紑灞曘€傜爺绌剁粨鏋滄樉绀猴紝鑺︽矁缇庢浛灏煎湪棰呭AVM鎴愪汉鎮h€呬腑鍩轰簬DSA璇勪及鐨勫瑙傜紦瑙g巼杈?4.3%锛?5% CI 35.1鈥?7.2锛夛紝鍏朵腑35.7%杈惧埌娣卞害缂撹В锛堢梾鐏剁缉灏忊墺50%锛夛紝瀹夊叏鎬х壒寰佹棦寰€鎶ラ亾涓€鑷翠笖鍙鐞嗐€傝繖涓€鎴愭灉鏄姦娌冪編鏇垮凹浠庣綍瑙佽偪鐦ら鍩熷悜琛€绠$暩褰㈡不鐤楁嫇灞曠殑閲嶈鎺㈢储锛屼害鏄绠$嚎鍦ㄧ簿鍑嗘不鐤楄竟鐣屼笂鐨勫張涓€杩涘睍銆?

鐮旂┒鑳屾櫙
鐮旂┒璁捐
鐤楁晥鏁版嵁
瀹夊叏鎬х壒寰佸彲鎺у彲绠$悊
缁撹
鏈澶т細鍏竷鐨勭爺绌剁粨鏋滆〃鏄庯紝鑺︽矁缇庢浛灏煎湪棰呭AVM涓睍鐜板嚭鍙枩鐨勪复搴婄枟鏁堝拰鍙鐞嗙殑瀹夊叏鎬х壒寰併€傞澶朅VM灏氭棤鏍囧噯绯荤粺娌荤枟鏂规锛岃€屾湰鐮旂┒鐨勪复搴婅瘉鎹负鏃犵枒涓鸿繖涓€棰嗗煙鐨勬不鐤楃┖鐧芥彁渚涗簡鍒濇寰瘉渚濇嵁銆傝姦娌冪編鏇垮凹鍦ˋVM涓殑涓村簥浠峰€煎皢鍦ㄥ悗缁复搴婄爺绌朵腑杩涜杩涗竴姝ョ殑楠岃瘉锛屾湁鏈涗负鎮h€呮彁渚涗竴绉嶉澏鍚戞不鐤楁柊閫夋嫨銆?
鍙傝€冩枃鐚細
1. Chen Hua, et al. Efficacy and Safety of Luvometinib, a MEK1/2 Inhibitor in Patients with Extracranial Arteriovenous Malformations: A Phase II Study. Presented at: 聽ISSVA World Congress 2026; May 19-22, 2026. Abstract 146.
鏈潗鏂欎负涓撲笟鍖诲璧勬枡锛屼粎渚涘尰鐤楀崼鐢熶笓涓氫汉澹弬鑰冿紝涓嶆瀯鎴愪换浣曟不鐤楀缓璁€?
鑱旂郴鏂瑰紡

濯掍綋锛?/span>pr@ksxdajs.com
鎶曡祫浜猴細ir@ksxdajs.com










